Clinical benefits of probiotic canine-derived Bifidobacterium animalis strain AHC7 in dogs with acute idiopathic diarrhea.
This study evaluated the effect of supplementation with canine-derived probiotic Bifidobacterium animalis strain AHC7 (lams Prostora, Procter & Gamble Pet Care) on the resolution rate of acute idiopathic diarrhea in dogs randomly assigned to receive a placebo (n=18) or the probiotic (n=13). Nutritional management with the probiotic fed at 2 x 10(10) CFU/day significantly reduced the time to resolution (3.9 +/- 2.3 versus 6.6 +/- 2.7 days; P < .01) and reduced the percentage of dogs that were administered metronidazole (38.5% versus 50.0%) compared with placebo. Probiotic B. animalis AHC7 may provide veterinarians another tool for management of acute diarrhea in dogs.
Kelley
R L
RL
Procter & Gamble Pet Care Technical Center 6571 State Route 503 North Lewisburg, OH 45338, USA. kelley.rl@pg.com
Minikhiem
Debbie
D
Kiely
Barry
B
O'Mahony
Liam
L
O'Sullivan
David
D
Boileau
Tom
T
Park
Jean Soon
JS
D000821:Animal Feed / Q000032:analysis*; D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001644:Bifidobacterium; D003967:Diarrhea / Q000628:therapy / Q000662:veterinary*; D004032:Diet / Q000662:veterinary*; D004283:Dog Diseases / Q000628:therapy*; D004285:Dogs; D008795:Metronidazole / Q000627:therapeutic use; D019936:Probiotics
D000890:Anti-Infective Agents; D008795:Metronidazole